Objective: To determine the impediments to the effective reduction of maternal-infant transmission of HIV in the municipality of Campos dos Goytacazes, RJ, Brazil.
Introduction
In Brazil, the rate of HIV infection among pregnant women is 0.6%, 1 and preventing maternal-infant transmission (MIT) of HIV is a directive from Coordenação Nacional de DST e AIDS (National STD and AIDS Program). 2 In the absence of any sort of intervention, rates of MIT of HIV are around 30 percent, though they may be cut down by 66 percent with the use of Zidovudine from the 14th week of pregnancy onwards, intravenously during delivery, and administered orally to the newborn during the first six weeks of life (Protocol ACTG 076). 3 Its use for shorter periods also decreases rates of MIT of HIV. 4 In developed countries, where every strategy is employed to prevent MIT of HIV, transmission rates range from 1 to 2 percent. In the developing world, high perinatal Persistent operational challenges lead to non-reduction in maternal-infant transmission of HIV Regina Célia de Souza Campos Fernandes, 1 Gustavo Fernandes Ribas, 2 Danielli Pires e Silva, 3 Alexandre Machado Gomes, 4 Enrique Medina-Acosta 5 transmission persists due to the difficulty in diagnosing all infected pregnant women and submitting them to treatment or prophylaxis with antiretrovirals; and due to postpartum transmission via breastfeeding, which remains a major challenge. 5 In Brazil, Protocol ACTG 076 has been in use since 1996.
Universidade Federal do Rio de Janeiro had an especially successful experience with the protocol, and its Programa de Assistência Integral à Gestante HIV (Full Health Care for Pregnant Women with HIV Program) reported a rate of MIT of HIV of 1.6 percent. 6 With triple therapy for pregnant women, the study by Escola Paulista de Medicina recorded absence of HIV infection in 111 children exposed to the virus. 7 More recently, a multicenter study by Sociedade The present study sought to describe the changes that took place from 2004 to 2007, in an attempt to review the strategies used to warrant a more effective prevention of MIT of HIV in the future.
Methods

Study design
This was an observational, prospective, longitudinal, analytic, concurrent cohort study that sought to determine the impediments to the effective reduction of MIT of HIV in the municipality of Campos dos Goytacazes, Rio de Janeiro, Brazil
Research subjects
The research included all pregnant women with confirmed pregnancy, viral load, CD4 counts, and maternal prophylaxis or treatment. The data from the questionnaire were managed using the application EpiData version 3.1 13 and analyzed using application EpiData Analysis V2.2.1.171.
Statistical analysis
Frequencies of variables were determined and bivariate analysis performed for exposure and dependent variables. 
Ethical considerations
The present study was approved by the Research Ethics Committee of Faculdade de Medicina de Campos.
Results
During the study period, on average 3,692 pregnant women received medical assistance annually, which corresponds to half the total number of pregnant women in the municipality, with little progress in recruitment throughout the study period ( Table 1) .
The cohort had greater use of cesarean sections, and predominant rupture of membranes at delivery and birth weight equal to or above 2,500 g, all variables associated with lower rates of MIT of HIV (Table 2) .
Low maternal age (< 30 years old) was predominant, as was low education (< or equal to complete secondary education). Most pregnant women were aware of the risk of MIT of HIV and its prevention. Diagnosis of maternal disease before pregnancy was 38.5 percent and confirmed during the prenatal period in 48.7 percent of cases. When diagnosis of maternal infection was performed during the postpartum period, MIT of HIV was statistically significant. Not breastfeeding consists in a protective factor for MIT of HIV (Table 3) .
MIT of HIV
Maternal viral load and CD4 counts, when assessed, had no statistically significant association with MIT of HIV.
Non-use of prophylaxis or treatment during pregnancy had a statistically significant association with MIT of HIV (Table 4) .
At endpoint, the investigation on MIT of HIV found that six children exposed to the virus were infected, the transmission rate being 7.7 percent. We analyzed their medical records to explain why each of the six infants was infected. Three mothers were diagnosed by rapid anti-HIV screening test: one before delivery, and the other two postpartum. In the first case, the child was born preterm, weighing 1,930 g, and cesarean section was performed after rupture of membranes. In the other two cases, mothers did not receive Zidovudine intravenously during delivery;
one delivered vaginally, the other by cesarean section after rupture of membranes, and both infants were breastfed.
In the fourth case, maternal HIV infection was diagnosed during pregnancy; the patient received triple therapy with Zidovudine, Lamivudine and Nelfinavir, delivered by cesarean section, and did not breastfeed. In this case, poor adherence to treatment on the part of the mother was implicated as cause. In the fifth, the patient had confirmed diagnosis before pregnancy and had been part of multiple treatment plans, always with poor compliance. Elective cesarean section was performed on the 38th week; the mother, with high viral load and severe immunodepression, suffered reactivation of toxoplasmosis and died. 15 The newborn, as well as infected with HIV, was also diagnosed with congenital toxoplasmosis. The case is a good example of what should be our greatest challenge in coming years: providing care to pregnant women in advanced stages of the disease, as well as treatment and follow-up for their infected children. 16 The sixth infected child was delivered vaginally, and her mother was also diagnosed in the postpartum period using rapid screening test. At 9 months old, her first viral load was undetectable, and follow-up was interrupted. At 3 years old, when diagnosis of HIV infection for her sister was confirmed, the girl was tested once again and serology results came back positive; the attending clinician learned her mother had resumed breastfeeding. In cases with birth weight below 2,500 g, relative risk
of MIT of HIV was high. This points to possibility of more advanced maternal disease, as well as treatment with protease inhibitors, which are associated with preterm birth and, consequently, low birth weight. [19] [20] [21] The pregnant women in this study were predominantly young, 30 years old or less, and had low education levels, matching current epidemiological trends in Brazil, i.e., the feminization and pauperization of the disease. The rate of MIT of HIV of 7.7% determined in this study is very high when compared to that of other studies: in Spain (1.42%), 25 a rural province in China (1%), 26 the European Collaborative Study (1.72%), 24 and South Africa (4.9%). 27 It is also high when compared to other Brazilian studies, [6] [7] [8] Each new child infected with HIV by MIT should be faced as a sentinel failure event in care provided to pregnant women, and requiring judicious analysis of the situation.
